Validation of a model for the prediction of retinopathy in persons with type 1 diabetes

Retinal Diseases

Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort

Br J Ophthalmol

Smith JJ, Wright DM, Stratton IM, Scanlon PH, Lois N

doi: 10.1136/bjophthalmol-2020-318570

Retinal Diseases

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Acta Ophthalmol.

van der Heijden AA, Abramoff MD, Verbraak F, van Hecke MV, Liem A, Nijpels G

doi: 10.1111/aos.13613.

Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model

JAMA Ophthalmol.

Binenbaum G, Ying GS, Tomlinson LA; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group

doi: 10.1001/jamaophthalmol.

Validation of the Colorado Retinopathy of Prematurity Screening Model

JAMA Ophthalmol.

McCourt EA, Ying GS, Lynch AM, Palestine AG, Wagner BD, Wymore E, Tomlinson LA, Binenbaum G

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes

Acta Ophthalmol

Veiby NCBB, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Petrovski G, Margeirsdottir HD

doi: 10.1111/aos.15018

Retinal Diseases

Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.

Ophthalmology.

Chong YH, Fan Q, Tham YC, Gan A, Tan SP, Tan G, Wang JJ, Mitchell P, Wong TY, Cheng CY

doi: 10.1016/j.ophtha.2016.11.016.

Macular DiseasesRetinal Diseases

Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy

JAMA Ophthalmol.

Ting DSW, Tan GSW, Agrawal R, Yanagi Y, Sie NM, Wong CW, San Yeo IY, Lee SY, Cheung CMG, Wong TY

doi: 10.1001/

Retinal Diseases

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

JAMA Ophthalmol.

Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, Kiss S, Silva PS, Wykoff CC, Sun JK, Diabetic Retinopathy Clinical Research Network

doi: 10.1001/jamaophthalmol.

Retinal DiseasesFurther Publications

Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients

Invest Ophthalmol Vis Sci

Hu Y, Chan Z, Li C, Shi Y, She X, Gu C, Wang Y, Zhou C, Zhao S, Zheng Z, Chen H

doi: 10.1167/iovs.62.4.23

Related content

Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model

Validation of the Colorado Retinopathy of Prematurity Screening Model

Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes

Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.

Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients